Oligonucleotide Drug Development (CMC)
Recent years have seen a huge surge of interest in oligonucleotide therapeutics, fueled by major advances in our understanding of...
Continue ReadingKnowledge Library
Oligonucleotide Drug Discovery
Recent years have seen a huge surge of interest in oligonucleotide therapeutics, fueled by major advances in our understanding of...
Continue Reading Pain Discovery Assays & In Vivo Models
WuXi AppTec offers a comprehensive platform to evaluate lead candidates targeting various types of pain, including inflammatory, neuropathic, and fibromyalgia-like...
Continue Reading OncoWuXi Newsletter: June 2022
WuXi AppTec xenograft and syngeneic tumor models in rats and CD47-related in vitro assay platform
Continue Reading WuXi AppTec Biology Services
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to...
Continue Reading Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase
Structure-based design was utilized to optimize 6,6-diaryl substituted dihydropyrone and hydroxylactam to obtain inhibitors of lactate dehydrogenase (LDH) with low...
Continue Reading